Follow
Ava John-Baptiste
Title
Cited by
Cited by
Year
The effect of English language proficiency on length of stay and in-hospital mortality
A John-Baptiste, G Naglie, G Tomlinson, SMH Alibhai, E Etchells, ...
Journal of general internal medicine 19, 221-228, 2004
3702004
Sustained responders have better quality of life and productivity compared with treatment failures long after antiviral therapy for hepatitis C
AA John-Baptiste, G Tomlinson, PC Hsu, M Krajden, JE Heathcote, ...
Official journal of the American College of Gastroenterology| ACG 104 (10 …, 2009
1132009
Antithrombotic treatment after coronary artery bypass graft surgery: systematic review and network meta-analysis
K Solo, S Lavi, C Kabali, GN Levine, A Kulik, AA John-Baptiste, ...
bmj 367, 2019
1042019
Preventing pressure ulcers in long-term care: a cost-effectiveness analysis
A Stern, W Chen, B Sander, A John-Baptiste, HH Thein, T Gomes, ...
Archives of internal medicine 171 (20), 1839-1847, 2011
1012011
The natural history of hepatitis C infection acquired through injection drug use: meta-analysis and meta-regression
A John-Baptiste, M Krahn, J Heathcote, A Laporte, G Tomlinson
Journal of hepatology 53 (2), 245-251, 2010
882010
Cost-effectiveness analyses of hepatitis A vaccine: a systematic review to explore the effect of methodological quality on the economic attractiveness of vaccination strategies
AM Anonychuk, AC Tricco, CT Bauch, B Pham, V Gilca, B Duval, ...
Pharmacoeconomics 26, 17-32, 2008
842008
Reducing otolaryngology surgical inefficiency via assessment of tray redundancy
CJ Chin, LJ Sowerby, A John-Baptiste, BW Rotenberg
Journal of Otolaryngology-Head & Neck Surgery 43 (1), 46, 2014
582014
Assessing the impact of a home-based stroke rehabilitation programme: a cost-effectiveness study
L Allen, A John-Baptiste, M Meyer, M Richardson, M Speechley, D Ure, ...
Disability and rehabilitation 41 (17), 2060-2065, 2019
452019
Potential cost-effectiveness of a preventive hepatitis C vaccine in high risk and average risk populations in Canada
MD Krahn, A John-Baptiste, Q Yi, A Doria, RS Remis, P Ritvo, S Friedman
Vaccine 23 (13), 1549-1558, 2005
432005
Comparing surgical trays with redundant instruments with trays with reduced instruments: a cost analysis
A John-Baptiste, LJ Sowerby, CJ Chin, J Martin, BW Rotenberg
Canadian Medical Association Open Access Journal 4 (3), E404-E408, 2016
382016
Is SABR cost-effective in oligometastatic cancer? An economic analysis of the SABR-COMET randomized trial
XM Qu, Y Chen, GS Zaric, S Senan, RA Olson, S Harrow, A John-Baptiste, ...
International Journal of Radiation Oncology* Biology* Physics 109 (5), 1176-1184, 2021
332021
A systematic review and methodological evaluation of published cost-effectiveness analyses of aromatase inhibitors versus tamoxifen in early stage breast cancer
AA John-Baptiste, W Wu, P Rochon, GM Anderson, CM Bell
PLoS One 8 (5), e62614, 2013
322013
Treatment of hepatitis C infection for current or former substance abusers in a community setting
A John‐Baptiste, M Varenbut, M Lingley, T Nedd‐Roderique, D Teplin, ...
Journal of viral hepatitis 16 (8), 557-567, 2009
312009
Cost effectiveness of hepatitis C-related interventions targeting substance users and other high-risk groups: a systematic review
A John-Baptiste, MW Yeung, V Leung, G van der Velde, M Krahn
Pharmacoeconomics 30, 1015-1034, 2012
242012
Measurement and prognosis of frail patients undergoing transcatheter aortic valve implantation: a systematic review and meta-analysis
Z Li, E Dawson, J Moodie, J Martin, R Bagur, D Cheng, B Kiaii, A Hashi, ...
BMJ open 11 (3), e040459, 2021
232021
Industry sponsored bias in cost effectiveness analyses
A John-Baptiste, C Bell
BMJ 341, 2010
222010
Liquid-based techniques for cervical cancer screening: Systematicreview and cost-effectiveness analysis
M Krahn, M McLachlin, B Pham, B Rosen, B Sander, P Grootendorst, ...
Technology report, 2008
192008
A glimpse into the black box of cost-effectiveness analyses
AA John-Baptiste, C Bell
CMAJ 183 (6), E307-E308, 2011
162011
Potential savings of harmonising hospital and community formularies for chronic disease medications initiated in hospital
L Lapointe-Shaw, HD Fischer, A Newman, A John-Baptiste, GM Anderson, ...
PLOS one 7 (6), e39737, 2012
132012
Cost-effectiveness analysis of frailty assessment in older patients undergoing coronary artery bypass grafting surgery
Z Li, S Habbous, J Thain, DE Hall, AD Nagpal, R Bagur, B Kiaii, ...
Canadian Journal of Cardiology 36 (4), 490-499, 2020
122020
The system can't perform the operation now. Try again later.
Articles 1–20